Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intravenous Iron Sucrose for Acute Decompensated Heart Failure Patients With Reduced Ejection Fraction and Iron Deficiency

NCT06703411 is registered in ClinicalTrials.gov with Cheng-Hsin General Hospital as lead sponsor.

NCT NCT06703411
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06703411 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intravenous Iron Sucrose for Acute Decompensated Heart Failure Patients With Reduced Ejection Fraction and Iron Deficiency
Lead sponsor
Cheng-Hsin General Hospital
Phase
Phase 4
Overall status
Completed
Start date
May 1, 2023
Completion date
October 31, 2024
Enrollment
76 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure with reduced ejection fraction (hfref), hospitalization, iron deficiency